Breast fibroadenoma

disease
On this page

Also known as FAfibroadenomafibroadenoma of breastfibroadenoma of the breastfibroadenoma, benignjuvenile fibroadenoma (morphologic abnormality)

Summary

Breast fibroadenoma (MONDO:0002056) is a disease and 22 clinical trials. Top therapeutic interventions include tamoxifen. A subtype of breast benign neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 22

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namebreast fibroadenoma
Mondo IDMONDO:0002056
MeSHD018226
DOIDDOID:1618
ICD-11143326763
NCITC3744
SNOMED CT254847007
UMLSC0178421
MedGen64231
Is cancer (heuristic)no

Also known as: breast fibroadenoma · FA · fibroadenoma · fibroadenoma of breast · fibroadenoma of the breast · fibroadenoma, benign · juvenile fibroadenoma (morphologic abnormality)

Disease family

This is a subtype of breast benign neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumorneoplastic disease or syndromeneoplasmbenign neoplasmthoracic benign neoplasmbreast benign neoplasmbreast fibroadenoma

Related subtypes (14): breast lipoma, breast cyst, benign eccrine breast spiradenoma, breast leiomyoma, breast adenoma, breast myofibroblastoma, benign breast adenomyoepithelioma, breast hemangioma, multiple fibroadenoma of the breast, benign breast phyllodes tumor, intraductal breast papilloma, benign neoplasm of male breast, diabetic mastopathy, lymphocytic mastitis

Subtypes (3): breast pericanalicular fibroadenoma, breast intracanalicular fibroadenoma, breast giant fibroadenoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 22.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified18
PHASE41
PHASE31
PHASE21
EARLY_PHASE11

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00999921PHASE4COMPLETEDEffects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer
NCT00147108PHASE3TERMINATEDMR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas
NCT03715413PHASE2COMPLETEDAnalgesic Efficacy of Pulsed Radiofrequency in Non-cyclic Mastalgia
NCT04341129EARLY_PHASE1COMPLETEDAbbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
NCT05219695Not specifiedRECRUITINGMedical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)
NCT06779656Not specifiedNOT_YET_RECRUITINGRegional Anesthesia Techniques in Breast Surgery
NCT07505797Not specifiedRECRUITINGATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
NCT00910312Not specifiedCOMPLETEDICE-SENSE™ Cryotherapy for Breast Fibroadenoma Trial
NCT01331954Not specifiedUNKNOWNTreatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)
NCT01422629Not specifiedCOMPLETEDHigh Intensity Focused Ultrasound (HIFU) to Treat Breast Fibroadenoma
NCT02011919Not specifiedCOMPLETEDTreatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)
NCT02078011Not specifiedCOMPLETEDTreatment of Breast Fibroadenoma With High Intensity Focused Ultrasound
NCT02139683Not specifiedCOMPLETEDFeasibility Study Assessing the Treatment of Fibroadenomata With a Circumferential Sonication Treatment With HIFU
NCT02488655Not specifiedCOMPLETEDTreatment of Breast Fibroadenoma With FastScan HIFU
NCT03022695Not specifiedCOMPLETEDTreatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)
NCT03044054Not specifiedCOMPLETEDTreatment of Breast Fibroadenoma Targeted Tissue With HIFU
NCT03470051Not specifiedCOMPLETEDCase Collection Study in the Evaluation of Doubling Time Rates in Non-Suspicious Breast Masses Using QT Ultrasound Technology
NCT03742401Not specifiedTERMINATEDTreatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)
NCT03868475Not specifiedWITHDRAWNComparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions
NCT04297007Not specifiedCOMPLETEDPectoral Nerve Block Type-II and Rhomboid Intercostal Block for Pain Management Following Mastectomy Surgery
NCT06016790Not specifiedCOMPLETEDExploring a Breast Cancer Early Screening Model Based on cfDNA
NCT06026176Not specifiedCOMPLETEDPattern of Clinical Presentation of Different Breast Disease in Surgical Opd at BPKIHS

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
TAMOXIFEN44